ethidium bromide has been researched along with hoe 33342 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishnan, L; Janvilisri, T; Reuter, G; Shahi, S; van Veen, HW; Venter, H | 1 |
| Schneider, HJ | 1 |
| Aravena, Mde L; Bruno, AM; Cabrera, M; Cascante, M; Cerecetto, H; González, M; Lavaggi, ML; López de Ceráin, A; Monge, A; Olea-Azar, C; Pachón, G; Pietrasanta, LI | 1 |
| Ajitha, A; Akunuri, R; Kamal, A; Kovvuri, J; Nagaraju, B; Nagesh, N; Nayak, VL; Rao, MPN | 1 |
1 review(s) available for ethidium bromide and hoe 33342
| Article | Year |
|---|---|
Ligand binding to nucleic acids and proteins: Does selectivity increase with strength?
Topics: Ligands; Nucleic Acids; Proteins; Receptors, Opioid; Substrate Specificity | 2008 |
3 other study(ies) available for ethidium bromide and hoe 33342
| Article | Year |
|---|---|
Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis.
Topics: Antineoplastic Agents, Hormonal; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cholesterol; Estradiol; Gene Expression; Humans; Lactococcus lactis; Neoplasm Proteins; Progesterone; Sterols; Tamoxifen; Testosterone; Tritium | 2003 |
Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation.
Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Hypoxia; Cell Line; Colonic Neoplasms; Cricetinae; DNA Damage; DNA Fragmentation; Humans; Phenazines | 2010 |
Design, synthesis and biological evaluation of new β-carboline-bisindole compounds as DNA binding, photocleavage agents and topoisomerase I inhibitors.
Topics: Antineoplastic Agents; Binding Sites; Carbolines; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Indoles; Molecular Docking Simulation; Molecular Structure; Photosensitizing Agents; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2018 |